144690-97-1 Usage
Molecular structure
The compound has a complex molecular structure with a heterocyclic imidazole ring and a carboxylic acid functional group, as well as a biphenyl moiety and a tertiary amine functional group substituted with a t-butyl carbamoyl group. It also has a hydroxyethyl and isopropyl group attached to the carbon backbone.
Functional groups
The compound contains several functional groups, including an imidazole ring, a carboxylic acid group, a biphenyl group, a tertiary amine group, a t-butyl carbamoyl group, a hydroxyethyl group, and an isopropyl group.
Ester compound
The compound is an ester of 1H-imidazole-5-carboxylic acid, which means it has an ethoxycarbonyl group attached to the imidazole ring.
Potential applications
Given its complex structure and diverse functional groups, the compound may have various applications in pharmaceuticals, materials science, or organic synthesis.
Physical and chemical properties
The physical and chemical properties of the compound are not specified in the given material, but they may vary depending on the specific functional groups and molecular structure.
Molecular weight
The molecular weight of the compound is not specified in the given material, but it can be calculated based on its molecular formula.
Check Digit Verification of cas no
The CAS Registry Mumber 144690-97-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,4,6,9 and 0 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 144690-97:
(8*1)+(7*4)+(6*4)+(5*6)+(4*9)+(3*0)+(2*9)+(1*7)=151
151 % 10 = 1
So 144690-97-1 is a valid CAS Registry Number.
144690-97-1Relevant articles and documents
ANGIOTENSIN II ANTAGONIST 1-BIPHENYLMETHYLIMIDAZOLE COMPOUNDS AND THEIR THERAPEUTIC USE
-
, (2008/06/13)
Compounds of the following formula (I) or the formula (I) p : STR1 wherein R 1 is alkyl or alkenyl; R 2 and R 3 are hydrogen, alkyl, alkenyl, cycloalkyl, aralkyl, aryl, or aryl fused to cycloalkyl; R 4 is hydrogen, alkyl, alkanoyl, alkenoyl, arylcarbonyl, alkoxycarbonyl, tetrahydropyranyl, tetrahydrothiopyranyl, tetrahydrothienyl, tetrahydrofuryl, a group of formula--SiR a R b R c, in which R a, R b and R c are alkyl or aryl, alkoxymethyl, (alkoxyalkoxy)methyl, haloalkoxymethyl, aralkyl, aryl or alkanoyloxymethoxycarbonyl; R 5 is carboxy or--CONR 8 R 9, wherein R 8 and R 9 hydrogens or alkyl, or R 8 and R 9 together form alkylene; R 6 is hydrogen, alkyl, alkoxy or halogen; R. sup.7 is carboxy or tetrazol-5-yl; R p. sup.1 is hydrogen, alkyl, cycloalkyl or alkanoyl; R p 2 is a single bond, alkylene or alkylidene; R p 3 and R p 4 are each hydrogen or alkyl; R. sub.p 6 is carboxy or tetrazol-5-yl; and X p is oxygen or sulfur; and pharmaceutically acceptable salts and esters thereof. The compounds are AII receptor antagonists and thus have hypotensive activity and can be used for the treatment and prophylaxis of hypertension. The compounds may be prepared by reacting a biphenylmethyl compound with an imidazole compound.